Literature DB >> 22802671

LSD1/CoREST is an allosteric nanoscale clamp regulated by H3-histone-tail molecular recognition.

Riccardo Baron1, Nadeem A Vellore.   

Abstract

The complex of lysine-specific demethylase-1 (LSD1/KDM1A) with its corepressor protein CoREST is an exceptionally relevant target for epigenetic drugs. Here, we provide insight into the local and global changes of LSD1/CoREST conformational dynamics that occur upon H3 binding on the basis of a total cumulative time of one microsecond molecular dynamics simulation. The LSD1/CoREST complex functions as an allosteric nanoscale-binding clamp, which is regulated by substrate binding. In the unbound state, LSD1/CoREST reversibly visits clamp states that are more open or significantly more closed compared with the available X-ray crystal structures. The Lys triad of residues Lys355, Lys357, and Lys359 gates the entrance of the H3 pocket. H3 binding shifts the pocket breathing dynamics toward open, higher-volume states while reducing the overall flexibility of the LSD1/CoREST nanoscale clamp. We show that the H3 pocket is an allosteric site for the regulation of the rotation of the amino oxidase domain with respect to the Tower domain. The allosteric mechanism relies on the specific reduction of nanoscale domain rotation upon local H3-tail binding. Instead, clamp opening/closing motions that do not involve domain rotation only reduce in amplitude yet are dominant in the bound state. Overall, our data suggest that the H3 binding pocket is a central target site to (i) switch off LSD1 amino oxidase activity, thus H3-tail demethylation; (ii) block the competitive binding of transcription factors; and (iii) prevent chromatin anchoring to LSD1/CoREST. This study underscores the importance of receptor flexibility for future epigenetic drug discovery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22802671      PMCID: PMC3411975          DOI: 10.1073/pnas.1207892109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia.

Authors:  Tino Schenk; Weihsu Claire Chen; Stefanie Göllner; Louise Howell; Liqing Jin; Katja Hebestreit; Hans-Ulrich Klein; Andreea C Popescu; Alan Burnett; Ken Mills; Robert A Casero; Laurence Marton; Patrick Woster; Mark D Minden; Martin Dugas; Jean C Y Wang; John E Dick; Carsten Müller-Tidow; Kevin Petrie; Arthur Zelent
Journal:  Nat Med       Date:  2012-03-11       Impact factor: 53.440

2.  A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6.

Authors:  Chris Oostenbrink; Alessandra Villa; Alan E Mark; Wilfred F van Gunsteren
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

Review 3.  Molecular mechanisms and potential functions of histone demethylases.

Authors:  Susanne Marije Kooistra; Kristian Helin
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

4.  Crystal structure and mechanism of human lysine-specific demethylase-1.

Authors:  Pete Stavropoulos; Günter Blobel; André Hoelz
Journal:  Nat Struct Mol Biol       Date:  2006-06-25       Impact factor: 15.369

5.  Targeting Histone Demethylases: A New Avenue for the Fight against Cancer.

Authors:  Dante Rotili; Antonello Mai
Journal:  Genes Cancer       Date:  2011-06

6.  Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.

Authors:  Philip Kahl; Lucia Gullotti; Lukas Carl Heukamp; Susanne Wolf; Nicolaus Friedrichs; Roland Vorreuther; Gerold Solleder; Patrick J Bastian; Jörg Ellinger; Eric Metzger; Roland Schüle; Reinhard Buettner
Journal:  Cancer Res       Date:  2006-12-01       Impact factor: 12.701

7.  Essential dynamics of proteins.

Authors:  A Amadei; A B Linssen; H J Berendsen
Journal:  Proteins       Date:  1993-12

8.  LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis.

Authors:  Xin Hu; Xingguo Li; Kristell Valverde; Xueqi Fu; Constance Noguchi; Yi Qiu; Suming Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-03       Impact factor: 11.205

9.  Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy.

Authors:  Johannes H Schulte; Soyoung Lim; Alexander Schramm; Nicolaus Friedrichs; Jan Koster; Rogier Versteeg; Ingrid Ora; Kristian Pajtler; Ludger Klein-Hitpass; Steffi Kuhfittig-Kulle; Eric Metzger; Roland Schüle; Angelika Eggert; Reinhard Buettner; Jutta Kirfel
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

Review 10.  Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancer.

Authors:  Oronza Antonietta Botrugno; Fabio Santoro; Saverio Minucci
Journal:  Cancer Lett       Date:  2009-04-02       Impact factor: 8.679

View more
  31 in total

1.  Local packing modulates diversity of iron pathways and cooperative behavior in eukaryotic and prokaryotic ferritins.

Authors:  Anatoly M Ruvinsky; Ilya A Vakser; Mario Rivera
Journal:  J Chem Phys       Date:  2014-03-21       Impact factor: 3.488

Review 2.  Chromatin regulation: how complex does it get?

Authors:  Karin Meier; Alexander Brehm
Journal:  Epigenetics       Date:  2014-11       Impact factor: 4.528

Review 3.  KDM1 class flavin-dependent protein lysine demethylases.

Authors:  Jonathan M Burg; Jennifer E Link; Brittany S Morgan; Frederick J Heller; Amanda E Hargrove; Dewey G McCafferty
Journal:  Biopolymers       Date:  2015-07       Impact factor: 2.505

4.  Antagonistic actions of Rcor proteins regulate LSD1 activity and cellular differentiation.

Authors:  Ghanshyam Upadhyay; Asif H Chowdhury; Bharat Vaidyanathan; David Kim; Shireen Saleque
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

5.  LSD1 Substrate Binding and Gene Expression Are Affected by HDAC1-Mediated Deacetylation.

Authors:  Dhanusha A Nalawansha; Mary Kay H Pflum
Journal:  ACS Chem Biol       Date:  2016-12-15       Impact factor: 5.100

6.  A specific LSD1/KDM1A isoform regulates neuronal differentiation through H3K9 demethylation.

Authors:  Benoit Laurent; Lv Ruitu; Jernej Murn; Kristina Hempel; Ryan Ferrao; Yang Xiang; Shichong Liu; Benjamin A Garcia; Hao Wu; Feizhen Wu; Hanno Steen; Yang Shi
Journal:  Mol Cell       Date:  2015-02-12       Impact factor: 17.970

7.  Targeting the histone demethylase LSD1 prevents cardiomyopathy in a mouse model of laminopathy.

Authors:  Anne-Claire Guénantin; Imen Jebeniani; Julia Leschik; Erwan Watrin; Gisèle Bonne; Nicolas Vignier; Michel Pucéat
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

8.  Order-disorder transition of intrinsically disordered kinase inducible transactivation domain of CREB.

Authors:  Hao Liu; Xiang Guo; Jingcheng Han; Ray Luo; Hai-Feng Chen
Journal:  J Chem Phys       Date:  2018-06-14       Impact factor: 3.488

9.  Crystal Structure of the LSD1/CoREST Histone Demethylase Bound to Its Nucleosome Substrate.

Authors:  Sang-Ah Kim; Jiang Zhu; Neela Yennawar; Priit Eek; Song Tan
Journal:  Mol Cell       Date:  2020-05-11       Impact factor: 17.970

10.  LSD1 activates a lethal prostate cancer gene network independently of its demethylase function.

Authors:  Archana Sehrawat; Lina Gao; Yuliang Wang; Armand Bankhead; Shannon K McWeeney; Carly J King; Jacob Schwartzman; Joshua Urrutia; William H Bisson; Daniel J Coleman; Sunil K Joshi; Dae-Hwan Kim; David A Sampson; Sheila Weinmann; Bhaskar V S Kallakury; Deborah L Berry; Reina Haque; Stephen K Van Den Eeden; Sunil Sharma; Jared Bearss; Tomasz M Beer; George V Thomas; Laura M Heiser; Joshi J Alumkal
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.